小児糖尿病治療の世界市場、規模、シェア、動向、産業分析レポート：タイプ別、治療別、投与経路別、用途別、流通チャネル別、地域別 - 市場予測、2025年～2034年

Polaris Market Research社の最新調査によると、小児糖尿病治療の市場規模は2034年までに346億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

小児糖尿病治療には、インスリン療法、経口抗糖尿病薬、GLP-1受容体作動薬、1型および2型糖尿病と診断された小児および青少年向けに設計されたデジタルグルコースモニタリング技術などが含まれます。同市場は、デジタル治療薬、統合型インスリン送達システム、リアルタイムグルコースモニタリングプラットフォームの採用増加により、著しい変貌を遂げています。

市場成長の主な要因は、小児の1型糖尿病罹患率の上昇、早期発症2型糖尿病診断の増加、遠隔モニタリングとデジタル治療プラットフォームの統合の増加です。小児に特化したインスリン送達システムの開発進展と、非インスリン療法に対する規制当局の承認拡大が、先進地域と新興地域における治療の利便性と市場拡大に寄与しています。

小児糖尿病治療市場レポートハイライト

タイプ別では、小児集団における高い有病率と生涯にわたるインスリン療法の必要性から、2024年に1型セグメントが最大シェアを占めました。

治療別では、インスリン療法分野が2024年の市場を独占しました。これは、小児糖尿病治療における重要な役割と、スマート＆デジタル統合型デリバリーシステムの採用拡大によるものです。

投与経路別では、臨床および在宅環境におけるインスリン注射とスマートデリバリーシステムの普及により、非経口投与セグメントが2024年に最大の市場シェアを占めました。

用途別では、小児の1型糖尿病と進行した2型糖尿病の主要治療薬であるインスリン製剤が2024年の市場を独占しました。

流通チャネルでは、病院セグメントが2024年の市場を独占しました。これは、診断件数の多さと先進治療へのアクセスが背景にあります。

北米は、構造化された小児内分泌医療とデジタル糖尿病管理技術の早期導入に後押しされ、2024年の世界小児糖尿病治療市場で大半のシェアを占めました。

アジア太平洋地域は、小児糖尿病患者の増加と政府の医療投資により、予測期間中に大きく成長する見込みです。

世界の主要市場プレイヤーには、Novo Nordisk A/S、Sanofi、Eli Lilly and Company、Medtronic plc、Abbott Laboratories、F. Hoffmann-La Roche Ltd、Dexcom Inc.、Insulet Corporation、Tandem Diabetes Care Inc.、Ascensia Diabetes Care Holdings AG、Glenmark Pharmaceuticals Ltd.、Biocon Limitedなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の小児糖尿病治療市場の洞察

• 市場スナップショット
• 小児糖尿病治療市場力学
  • 促進要因と機会
    • 世界中で小児における1型糖尿病の発症率が上昇
    • 遠隔モニタリングとデジタル治療の導入拡大
  • 抑制要因と課題
    • 高額な治療費とアクセスの制限
• PESTEL分析
• 小児糖尿病治療市場の動向
• バリューチェーン分析

第5章 世界の小児糖尿病治療市場：タイプ別

• 主な調査結果
• イントロダクション
• 1型
• 2型

第6章 世界の小児糖尿病治療市場：治療別

• 主な調査結果
• イントロダクション
• 薬物療法
• インスリン療法

第7章 世界の小児糖尿病治療市場：投与経路別

• 主な調査結果
• イントロダクション
• 経口投与
• 鼻腔投与
• 非経口投与

第8章 世界の小児糖尿病治療市場：用途別

• 主な調査結果
• イントロダクション
• インスリン
• GLP-1受容体作動薬
• ビグアニド
• SGLT2阻害剤
• その他

第9章 世界の小児糖尿病治療市場：流通チャネル別

• 主な調査結果
• イントロダクション
• 病院
• 専門クリニック
• 小売薬局
• ドラッグストア

第10章 世界の小児糖尿病治療市場：地域別

• 主な調査結果
• イントロダクション
  • 小児糖尿病治療市場評価：地域別、2020年～2034年
• 北米
  • 北米：タイプ別、2020～2034年
  • 北米：治療別、2020～2034年
  • 北米：投与経路別、2020～2034年
  • 北米：用途別、2020～2034年
  • 北米：流通チャネル別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：タイプ別、2020～2034年
  • 欧州：治療別、2020～2034年
  • 欧州：投与経路別、2020～2034年
  • 欧州：用途別、2020～2034年
  • 欧州：流通チャネル別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋地域
  • アジア太平洋地域：タイプ別、2020～2034年
  • アジア太平洋地域：治療別、2020～2034年
  • アジア太平洋地域：投与経路別、2020～2034年
  • アジア太平洋地域：用途別、2020～2034年
  • アジア太平洋地域：流通チャネル別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：タイプ別、2020～2034年
  • 中東・アフリカ：治療別、2020～2034年
  • 中東・アフリカ：投与経路別、2020～2034年
  • 中東・アフリカ：用途別、2020～2034年
  • 中東・アフリカ：流通チャネル別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：タイプ別、2020-2034年
  • ラテンアメリカ：治療別、2020～2034年
  • ラテンアメリカ：投与経路別、2020～2034年
  • ラテンアメリカ：用途別、2020～2034年
  • ラテンアメリカ：流通チャネル別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第11章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第12章 企業プロファイル

• Abbott Laboratories
• Ascensia Diabetes Care Holdings AG
• Biocon Limited
• Dexcom Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Glenmark Pharmaceuticals Ltd.
• Insulet Corporation
• Medtronic plc
• Novo Nordisk A/S
• Sanofi
• Tandem Diabetes Care Inc.

List of Tables:

• Table 1 Global Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 2 Global Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 3 Global Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 4 Global Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 5 Global Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 6 North America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 7 North America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 8 North America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 9 North America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 10 North America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 11 U.S.: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 12 U.S.: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 13 U.S.: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 14 U.S.: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 15 U.S.: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 16 Canada: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 17 Canada: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 18 Canada: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 19 Canada: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 20 Canada: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 21 Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 22 Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 23 Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 24 Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 25 Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 26 UK: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 27 UK: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 28 UK: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 29 UK: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 30 UK: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 31 France: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 32 France: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 33 France: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 34 France: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 35 France: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 36 Germany: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 37 Germany: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 38 Germany: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 39 Germany: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 40 Germany: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 41 Italy: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 42 Italy: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 43 Italy: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 44 Italy: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 45 Italy: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 46 Spain: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 47 Spain: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 48 Spain: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 49 Spain: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 50 Spain: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 51 Netherlands: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 52 Netherlands: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 53 Netherlands: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 54 Netherlands: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 55 Netherlands: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 56 Russia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 57 Russia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 58 Russia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 59 Russia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 60 Russia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 61 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 62 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 63 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 64 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 65 Rest of Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 66 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 67 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 68 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 69 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 70 Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 71 China: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 72 China: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 73 China: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 74 China: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 75 China: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 76 India: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 77 India: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 78 India: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 79 India: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 80 India: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 81 Malaysia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 82 Malaysia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 83 Malaysia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 84 Malaysia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 85 Malaysia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 86 Japan: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 87 Japan: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 88 Japan: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 89 Japan: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 90 Japan: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 91 Indonesia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 92 Indonesia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 93 Indonesia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 94 Indonesia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 95 Indonesia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 96 South Korea: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 97 South Korea: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 98 South Korea: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 99 South Korea: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 100 South Korea: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 101 Australia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 102 Australia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 103 Australia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 104 Australia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 105 Australia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 106 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 107 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 108 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 109 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 110 Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 111 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 112 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 113 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 114 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 115 Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 116 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 117 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 118 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 119 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 120 Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 121 UAE: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 122 UAE: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 123 UAE: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 124 UAE: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 125 UAE: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 126 Israel: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 127 Israel: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 128 Israel: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 129 Israel: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 130 Israel: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 131 South Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 132 South Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 133 South Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 134 South Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 135 South Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 136 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 137 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 138 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 139 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 140 Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 141 Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 142 Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 143 Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 144 Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 145 Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 146 Mexico: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 147 Mexico: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 148 Mexico: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 149 Mexico: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 150 Mexico: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 151 Brazil: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 152 Brazil: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 153 Brazil: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 154 Brazil: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 155 Brazil: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 156 Argentina: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 157 Argentina: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 158 Argentina: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 159 Argentina: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 160 Argentina: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• Table 161 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• Table 162 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• Table 163 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 164 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• Table 165 Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Pediatric Diabetes Therapeutic Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Type
• Figure 7. Global Pediatric Diabetes Therapeutic Market, by Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Therapy
• Figure 9. Global Pediatric Diabetes Therapeutic Market, by Therapy, 2024 & 2034 (USD Billion)
• Figure 10. Market by Route of Administration
• Figure 11. Global Pediatric Diabetes Therapeutic Market, by Route of Administration, 2024 & 2034 (USD Billion)
• Figure 12. Market by Application
• Figure 13. Global Pediatric Diabetes Therapeutic Market, by Application, 2024 & 2034 (USD Billion)
• Figure 14. Market by Distribution Channel
• Figure 15. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2024 & 2034 (USD Billion)

The pediatric diabetes therapeutics market size is expected to reach USD 34.60 Billion by 2034, according to a new study by Polaris Market Research. The report "Pediatric Diabetes Therapeutic Market Size, Share, Trends, & Industry Analysis Report By Type (Type 1, Type 2), By Therapy, By Route of Administration, By Application, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pediatric diabetes therapeutics include insulin therapies, oral antidiabetic drugs, GLP-1 receptor agonists and digital glucose monitoring technologies designed for children and adolescents diagnosed with type 1 and type 2 diabetes. The market is witnessing significant transformation through increased adoption of digital therapeutics, integrated insulin delivery systems, and real-time glucose monitoring platforms.

Market growth is primarily driven by the rising incidence of type 1 diabetes among children, growing diagnosis of early-onset type 2 diabetes and increasing integration of remote monitoring and digital therapeutic platforms. Growing advancements in pediatric-specific insulin delivery systems and expanding regulatory approvals for non-insulin therapies are contributing to treatment accessibility and market expansion across developed and emerging regions.

Pediatric Diabetes Therapeutic Market Report Highlights

Based on type, the type 1 segment accounted for largest share in 2024, due to high prevalence and the requirement for lifelong insulin therapy in pediatric populations.

In terms of therapy, the insulin therapy segment dominated the market in 2024. This is driven by its key role in pediatric diabetes care and growing adoption of smart & digitally integrated delivery systems.

Based on route of administration, the parenteral administration segment held the largest market share in 2024 due to its widespread adoption of insulin injections and smart delivery systems in clinical and home settings.

Based on application, the insulin segment dominated the market in 2024, as it remains the primary treatment for pediatric type 1 diabetes and advanced type 2 cases.

In terms of distribution channel, the hospitals segment dominated the market in 2024. This is fueled by high diagnosis volume and access to advanced therapies.

North America accounted for the majority share in the global pediatric diabetes therapeutic market in 2024, fueled by fueled by structured pediatric endocrinology care and early adoption of digital diabetes management technologies.

Asia Pacific is expected to grow significantly during the forecast period, fueled by increasing childhood diabetes cases and government healthcare investments.

A few global key market players include Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glenmark Pharmaceuticals Ltd., and Biocon Limited.

Polaris Market Research has segmented the market report on the basis of type, therapy, route of administration, application, distribution channel, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Type 1

Type 2

By Therapy Outlook (Revenue, USD Billion, 2020-2034)

Drug Therapy

Biguanide

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

Insulin Therapy

Rapid-acting Insulin

Short-acting Insulin

Intermediate-acting Insulin

Long-acting Insulin

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Oral Administration

Nasal Administration

Parenteral Administration

Subcutaneous

Intramuscular

Intravenous

By Application Outlook (Revenue, USD Billion, 2020-2034)

Insulin

GLP-1 Receptor Agonists

Biguanide

SGLT2 Inhibitors

Other Application

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Specialty Clinics

Retail Pharmacies

Drug Stores

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Pediatric Diabetes Therapeutic Market Insights

• 4.1. Pediatric Diabetes Therapeutic Market - Market Snapshot
• 4.2. Pediatric Diabetes Therapeutic Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Incidence of Type 1 Diabetes in Children Globally
    • 4.2.1.2. Growing Adoption of Remote Monitoring and Digital Therapeutics
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Treatment Costs and Limited Access
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Pediatric Diabetes Therapeutic Market Trends
• 4.6. Value Chain Analysis

5. Global Pediatric Diabetes Therapeutic Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
• 5.3. Type 1
  • 5.3.1. Global Pediatric Diabetes Therapeutic Market, by Type 1, by Region, 2020-2034 (USD Billion)
• 5.4. Type 2
  • 5.4.1. Global Pediatric Diabetes Therapeutic Market, by Type 2, by Region, 2020-2034 (USD Billion)

6. Global Pediatric Diabetes Therapeutic Market, by Therapy

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
• 6.3. Drug Therapy
  • 6.3.1. Global Pediatric Diabetes Therapeutic Market, by Drug Therapy, by Region, 2020-2034 (USD Billion)
• 6.4. Insulin Therapy
  • 6.4.1. Global Pediatric Diabetes Therapeutic Market, by Insulin Therapy, by Region, 2020-2034 (USD Billion)

7. Global Pediatric Diabetes Therapeutic Market, by Route of Administration

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
• 7.3. Oral Administration
  • 7.3.1. Global Pediatric Diabetes Therapeutic Market, by Oral Administration, by Region, 2020-2034 (USD Billion)
• 7.4. Nasal Administration
  • 7.4.1. Global Pediatric Diabetes Therapeutic Market, by Nasal Administration, by Region, 2020-2034 (USD Billion)
• 7.5. Parenteral Administration
  • 7.5.1. Global Pediatric Diabetes Therapeutic Market, by Parenteral Administration, by Region, 2020-2034 (USD Billion)

8. Global Pediatric Diabetes Therapeutic Market, by Application

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
• 8.3. Insulin
  • 8.3.1. Global Pediatric Diabetes Therapeutic Market, by Insulin, by Region, 2020-2034 (USD Billion)
• 8.4. GLP-1 Receptor Agonists
  • 8.4.1. Global Pediatric Diabetes Therapeutic Market, by GLP-1 Receptor Agonists, by Region, 2020-2034 (USD Billion)
• 8.5. Biguanide
  • 8.5.1. Global Pediatric Diabetes Therapeutic Market, by Biguanide, by Region, 2020-2034 (USD Billion)
• 8.6. SGLT2 Inhibitors
  • 8.6.1. Global Pediatric Diabetes Therapeutic Market, by SGLT2 Inhibitors, by Region, 2020-2034 (USD Billion)
• 8.7. Other Application
  • 8.7.1. Global Pediatric Diabetes Therapeutic Market, by Other Application, by Region, 2020-2034 (USD Billion)

9. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• 9.3. Hospitals
  • 9.3.1. Global Pediatric Diabetes Therapeutic Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 9.4. Specialty Clinics
  • 9.4.1. Global Pediatric Diabetes Therapeutic Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
• 9.5. Retail Pharmacies
  • 9.5.1. Global Pediatric Diabetes Therapeutic Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
• 9.6. Drug Stores
  • 9.6.1. Global Pediatric Diabetes Therapeutic Market, by Drug Stores, by Region, 2020-2034 (USD Billion)

10. Global Pediatric Diabetes Therapeutic Market, by Geography

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Pediatric Diabetes Therapeutic Market Assessment, By Geography, 2020-2034 (USD Billion)
• 10.3. Pediatric Diabetes Therapeutic Market - North America
  • 10.3.1. North America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • 10.3.2. North America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • 10.3.3. North America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • 10.3.4. North America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • 10.3.5. North America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.3.6. Pediatric Diabetes Therapeutic Market - U.S.
    • 10.3.6.1. U.S.: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.3.6.2. U.S.: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.3.6.3. U.S.: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.6.4. U.S.: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.3.6.5. U.S.: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.3.7. Pediatric Diabetes Therapeutic Market - Canada
    • 10.3.7.1. Canada: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.3.7.2. Canada: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.3.7.3. Canada: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.7.4. Canada: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.3.7.5. Canada: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• 10.4. Pediatric Diabetes Therapeutic Market - Europe
  • 10.4.1. Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • 10.4.2. Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • 10.4.3. Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • 10.4.4. Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • 10.4.5. Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.6. Pediatric Diabetes Therapeutic Market - UK
    • 10.4.6.1. UK: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.6.2. UK: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.6.3. UK: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.6.4. UK: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.6.5. UK: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.7. Pediatric Diabetes Therapeutic Market - France
    • 10.4.7.1. France: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.7.2. France: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.7.3. France: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.7.4. France: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.7.5. France: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.8. Pediatric Diabetes Therapeutic Market - Germany
    • 10.4.8.1. Germany: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.8.2. Germany: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.8.3. Germany: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.8.4. Germany: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.8.5. Germany: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.9. Pediatric Diabetes Therapeutic Market - Italy
    • 10.4.9.1. Italy: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.9.2. Italy: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.9.3. Italy: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.9.4. Italy: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.9.5. Italy: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.10. Pediatric Diabetes Therapeutic Market - Spain
    • 10.4.10.1. Spain: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.10.2. Spain: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.10.3. Spain: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.10.4. Spain: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.10.5. Spain: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.11. Pediatric Diabetes Therapeutic Market - Netherlands
    • 10.4.11.1. Netherlands: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.11.2. Netherlands: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.11.3. Netherlands: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.11.4. Netherlands: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.11.5. Netherlands: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.12. Pediatric Diabetes Therapeutic Market - Russia
    • 10.4.12.1. Russia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.12.2. Russia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.12.3. Russia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.12.4. Russia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.12.5. Russia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.4.13. Pediatric Diabetes Therapeutic Market - Rest of Europe
    • 10.4.13.1. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.4.13.2. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.13.3. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.13.4. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.4.13.5. Rest of Europe: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• 10.5. Pediatric Diabetes Therapeutic Market - Asia Pacific
  • 10.5.1. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • 10.5.2. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • 10.5.3. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • 10.5.4. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • 10.5.5. Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.6. Pediatric Diabetes Therapeutic Market - China
    • 10.5.6.1. China: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.6.2. China: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.6.3. China: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.6.4. China: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.6.5. China: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.7. Pediatric Diabetes Therapeutic Market - India
    • 10.5.7.1. India: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.7.2. India: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.7.3. India: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.7.4. India: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.7.5. India: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.8. Pediatric Diabetes Therapeutic Market - Malaysia
    • 10.5.8.1. Malaysia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.8.2. Malaysia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.8.3. Malaysia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.8.4. Malaysia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.8.5. Malaysia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.9. Pediatric Diabetes Therapeutic Market - Japan
    • 10.5.9.1. Japan: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.9.2. Japan: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.9.3. Japan: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.9.4. Japan: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.9.5. Japan: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.10. Pediatric Diabetes Therapeutic Market - Indonesia
    • 10.5.10.1. Indonesia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.10.2. Indonesia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.10.3. Indonesia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.10.4. Indonesia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.10.5. Indonesia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.11. Pediatric Diabetes Therapeutic Market - South Korea
    • 10.5.11.1. South Korea: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.11.2. South Korea: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.11.3. South Korea: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.11.4. South Korea: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.11.5. South Korea: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.12. Pediatric Diabetes Therapeutic Market - Australia
    • 10.5.12.1. Australia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.12.2. Australia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.12.3. Australia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.12.4. Australia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.12.5. Australia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.5.13. Pediatric Diabetes Therapeutic Market - Rest of Asia Pacific
    • 10.5.13.1. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.5.13.2. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.13.3. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.13.4. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.5.13.5. Rest of Asia Pacific: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• 10.6. Pediatric Diabetes Therapeutic Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • 10.6.2. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • 10.6.3. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • 10.6.4. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • 10.6.5. Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.6.6. Pediatric Diabetes Therapeutic Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.6.6.2. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.6.3. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.6.4. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.6.6.5. Saudi Arabia: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.6.7. Pediatric Diabetes Therapeutic Market - UAE
    • 10.6.7.1. UAE: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.6.7.2. UAE: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.7.3. UAE: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.7.4. UAE: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.6.7.5. UAE: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.6.8. Pediatric Diabetes Therapeutic Market - Israel
    • 10.6.8.1. Israel: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.6.8.2. Israel: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.8.3. Israel: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.8.4. Israel: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.6.8.5. Israel: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.6.9. Pediatric Diabetes Therapeutic Market - South Africa
    • 10.6.9.1. South Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.6.9.2. South Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.9.3. South Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.9.4. South Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.6.9.5. South Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.6.10. Pediatric Diabetes Therapeutic Market - Rest of Middle East & Africa
    • 10.6.10.1. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.6.10.2. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.10.3. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.10.4. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.6.10.5. Rest of Middle East & Africa: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
• 10.7. Pediatric Diabetes Therapeutic Market - Latin America
  • 10.7.1. Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
  • 10.7.2. Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
  • 10.7.3. Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
  • 10.7.4. Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
  • 10.7.5. Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.7.6. Pediatric Diabetes Therapeutic Market - Mexico
    • 10.7.6.1. Mexico: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.7.6.2. Mexico: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.6.3. Mexico: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.6.4. Mexico: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.7.6.5. Mexico: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.7.7. Pediatric Diabetes Therapeutic Market - Brazil
    • 10.7.7.1. Brazil: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.7.7.2. Brazil: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.7.3. Brazil: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.7.4. Brazil: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.7.7.5. Brazil: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.7.8. Pediatric Diabetes Therapeutic Market - Argentina
    • 10.7.8.1. Argentina: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.7.8.2. Argentina: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.8.3. Argentina: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.8.4. Argentina: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.7.8.5. Argentina: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 10.7.9. Pediatric Diabetes Therapeutic Market - Rest of Latin America
    • 10.7.9.1. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Type, 2020-2034 (USD Billion)
    • 10.7.9.2. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.9.3. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.9.4. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Application, 2020-2034 (USD Billion)
    • 10.7.9.5. Rest of Latin America: Pediatric Diabetes Therapeutic Market, by Distribution Channel, 2020-2034 (USD Billion)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. Abbott Laboratories
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Ascensia Diabetes Care Holdings AG
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. Biocon Limited
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. Dexcom Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. Eli Lilly and Company
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. F. Hoffmann-La Roche Ltd
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Benchmarking
  • 12.6.4. Recent Development
• 12.7. Glenmark Pharmaceuticals Ltd.
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Benchmarking
  • 12.7.4. Recent Development
• 12.8. Insulet Corporation
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Benchmarking
  • 12.8.4. Recent Development
• 12.9. Medtronic plc
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Benchmarking
  • 12.9.4. Recent Development
• 12.10. Novo Nordisk A/S
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Benchmarking
  • 12.10.4. Recent Development
• 12.11. Sanofi
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Benchmarking
  • 12.11.4. Recent Development
• 12.12. Tandem Diabetes Care Inc.
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Benchmarking
  • 12.12.4. Recent Development